Skip to main content
Caplight Logo









Sakura MedTech

Sakura MedTech

Private
Urbana, IllinoisHealthcare & Life Scienceshttps://www.sakuramedtech.com/

Last Round

Accelerator

Jun 22, 2023

Total Funding Raised

$85,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Sakura MedTech is a medical device company developing a patient-centric imaging device for cervical cancer screening to improve patient experience and gynecological efficiency.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

medical devicecervical cancer screeningminimally invasive imaginggynecological examinationwomen's health techfemtechdiagnostic hardwaremedical imaging softwarepatient experiencecomputer visionclinical workflowSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sakura MedTech Comparables

Compare Sakura MedTech with similar companies based on industry and business-model similarity.

Sakura MedTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lutech Industries
82%
Illumigyn
81%
Guided Therapeutics Inc
76%

Sakura MedTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 22, 2023
GrantApr 19, 2023
GrantFeb 28, 2023

Key People

Founding team and executive leadership

Priya K.

Founder & CEO

Founding Team

Sakura MedTech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Grew 57% QoQ, from 7 to 11 employees.

  • Apr 22, 2026

    Grew 57% QoQ from 7 to 11 employees.

Sakura MedTech Filings

Explore SEC and related filing metadata, where available.

Sakura MedTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sakura MedTech's valuation, stock price, and market status.

Is Sakura MedTech a public or private company?

Sakura MedTech is a private company.

What is the current stock price of Sakura MedTech?

Sakura MedTech is a private company with no public stock price. No recent secondary market data is available.

How much is Sakura MedTech worth (valuation)?

Valuation information for Sakura MedTech is not publicly available.

Can I buy Sakura MedTech stock?

Sakura MedTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sakura MedTech's last funding round?

Sakura MedTech's most recent funding round was Accelerator on June 22, 2023.

Who are the main investors in Sakura MedTech?

Key investors in Sakura MedTech include iVenture Accelerator, Polsky Center for Entrepreneurship and Innovation at the University of Chicago, Illinois Ventures.

Will Sakura MedTech IPO soon?

No public IPO plans have been announced for Sakura MedTech.

How can I track Sakura MedTech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sakura MedTech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUrbana, Illinois
Employee Range11
Year Founded2023
Last FundingJun 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?